Medicinal products for the treatment of blood diseases, hematopoietic organs, and cardiovascular system diseases

This tender concerns the procurement of medicinal products essential for treating conditions affecting the blood, hematopoietic organs, and the cardiovascular system. The specific item listed is Verapamil solution for injection, 2.5 mg/ml in 2 ml ampoules, falling under the CPV code 33620000-2 (Medicinal products for the treatment of blood diseases, hematopoietic organs, and cardiovascular system diseases). The procuring entity is the Communal Non-Profit Enterprise "Dnipro Center for Primary Health Care №1" of the Dnipro City Council.

A crucial aspect of submitting a price proposal for this tender is the confirmation that the origin of the goods is not the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. This declaration is a mandatory requirement for all participants. The tender focuses on ensuring the availability of vital medications for patients requiring treatment for these specific health conditions. The procurement aims to secure a reliable supply of high-quality pharmaceutical products to meet the healthcare needs of the population served by the Dnipro Center for Primary Health Care №1. Further details regarding the specific quantities, delivery schedules, and evaluation criteria will be provided in the full tender documentation.

This is a supplies contract in the health and medical services sector, with a focus on Primary Healthcare and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 480.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.